Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma

Beitrag in einer Fachzeitschrift


Details zur Publikation

Autorinnen und Autoren: Tognarelli S, Wirsching S, Von Metzler I, Rais B, Jacobs B, Serve H, Bader P, Ullrich E
Zeitschrift: Frontiers in Immunology
Jahr der Veröffentlichung: 2018
Band: 9
ISSN: 1664-3224


Abstract

Natural killer (NK) cells are innate lymphocytes with a strong antitumor ability. In tumor patients, such as multiple myeloma (MM) patients, an elevated number of NK cells after stem cell transplantation (SCT) has been reported to be correlated with a higher overall survival rate. With the aim of improving NK cell use for adoptive cell therapy, we also addressed the cytotoxicity of patient-derived, cytokine-stimulated NK cells against MM cells at specific time points: at diagnosis and before and after autologous stem cell transplantation. Remarkably, after cytokine stimulation, the patients' NK cells did not significantly differ from those of healthy donors. In a small cohort of MM patients, we were able to isolate autologous tumor cells, and we could demonstrate that IL-2/15 stimulated autologous NK cells were able to significantly improve their killing capacity of autologous tumor cells. With the aim to further improve the NK cell killing capacity against MM cells, we investigated the potential use of NK specific check point inhibitors with focus on NKG2A because this inhibitory NK cell receptor was upregulated following ex vivo cytokine stimulation and MM cells showed HLA-E expression that could even be increased by exposure to IFN-γ. Importantly, blocking of NKG2A resulted in a significant increase in the NK cell-mediated lysis of different MM target cells. Finally, these results let suggest that combining cytokine induced NK cell activation and the specific check point inhibition of the NKG2A-mediated pathways can be an effective strategy to optimize NK cell therapeutic approaches for treatment of multiple myeloma.


FAU-Autorinnen und Autoren / FAU-Herausgeberinnen und Herausgeber

Jacobs, Benedikt Dr. med.
Medizinische Klinik 5 - Hämatologie und Internistische Onkologie


Einrichtungen weiterer Autorinnen und Autoren

Goethe-Universität Frankfurt am Main


Zitierweisen

APA:
Tognarelli, S., Wirsching, S., Von Metzler, I., Rais, B., Jacobs, B., Serve, H.,... Ullrich, E. (2018). Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma. Frontiers in Immunology, 9. https://dx.doi.org/10.3389/fimmu.2018.02743

MLA:
Tognarelli, Sara, et al. "Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma." Frontiers in Immunology 9 (2018).

BibTeX: 

Zuletzt aktualisiert 2019-31-07 um 07:20